Funding

Modernizing Medicine Pulls In $38M

51 Views

What does Modernizing Medicine do?

Modernizing Medicine, is the creator of the Electronic Medical Assistant- EMA, which is a cloud based specialty specific electronic medical record system. The company is transforming how healthcare info is created, consumed and utilized in order to improve efficiency and outcomes. EMA is a specialty specific electronic medical record system with a library of built in medical content, designed for saving time for the physicians. It is available as a native iPad app or from web enabled PC or Mac. EMA adapts to every provider’s unique practicing style and is designed for the interface with hundreds of different practice management systems.

How much Modernizing Medicine was funded?

Modernizing Medicine raised $38M in Series E funding on September 21, 2015 from Pentland Group, Summit Partners and Sands Capital Ventures

Previous funding

  • $425k in Debt Financing on January 21, 2010
  • $7.1M in Venture on March 1, 2011
  • $12M in Venture round on December 5, 2012 from Pentland Group(Lead) and Sands Capital Ventures
  • $14M in Series C on August 20, 2013 from Summit Partners Partner: Mark A. deLaar
  • $15M in Series D round on November 11, 2014 from Pentland Group(Lead) and Summit Partners (Lead)
  • $5M in Undisclosed on March 19, 2015 from IBM
  • $10M in Debt Financing on August 31, 2015 from Silicon Valley Bank

What is next for Modernizing Medicine?

Modernizing Medicine is continuing to focus exclusively on the medical and surgical specialty markets. These are most difficult markets to provide software for and they are the best ones for the company’s solution because of how the solution was designed. The company has also recently launched a telemedicine solution. Almost everything in dermatology can be diagnosed using telemedicine
More about Modernizing Medicine

The company was founded on February 1st, 2010 by Dan Cane and Micael Sherling. It has its headquarters in Boca Raton, FL.

The company provides specialty specific offerings for orthopedics, dermatology, otolaryngology, ophthalmology, cosmetic and plastic surgery markets, and to over 1,300 physician practices across the country. In 2013 it was listed on Forbe’s annual ranking of America’s Most Promising Companies.

 

Related Posts